Skip to main content
Clinical Trials/NCT07170371
NCT07170371Active, not recruitingNot Applicable

Patient Education Program for Individuals With Rheumatoid Arthritis: A Randomized Controlled Trial

Hassan II University1 site in 1 country88 target enrollmentStarted: September 5, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
88
Locations
1
Primary Endpoint
AIMS2 Quality of life

Study Overview

Brief Summary

The goal of this clinical trial is to learn if a culturally adapted patient education program can help people with rheumatoid arthritis (RA) manage their disease and improve their quality of life. The main questions it aims to answer are:

  • Does the program improve patients' knowledge, self-management skills, and confidence in dealing with RA?
  • Does it lead to better quality of life and treatment adherence compared to usual care?

Participants will:

  • Join group sessions and individual activities focused on RA education, self-care, and stress management
  • Take part in the program for 6 months, with regular follow-up visits
  • Complete questionnaires about symptoms, daily activities, and quality of life

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults (≥18 years) diagnosed with rheumatoid arthritis according to ACR/EULAR 2010 classification criteria
  • •Stable pharmacological treatment for at least 3 months prior to enrollment
  • •Ability to participate in group sessions and complete questionnaires
  • •Provided written informed consent

Exclusion Criteria

  • •Diagnosis of other systemic autoimmune or inflammatory rheumatic diseases (e.g., lupus, psoriatic arthritis)
  • •Severe comorbidities that may interfere with participation (e.g., advanced heart failure, uncontrolled psychiatric illness)
  • •Cognitive impairment or language barrier preventing comprehension of the program
  • •Participation in another structured patient education program within the last 6 months

Arms & Interventions

Patient education Group

Experimental

A culturally adapted patient education program designed for individuals with rheumatoid arthritis. The program was developed through a structured needs assessment and based on established health behavior theories. It includes five core modules delivered over six months: understanding rheumatoid arthritis, monitoring disease activity, treatment strategies, nutrition, and stress management. Sessions combine group workshops and individual support, with interactive materials and practical exercises. The program aims to strengthen patients' knowledge, self-management skills, and quality of life compared to usual care.

Intervention: patient education (Other)

Usual care Group

Active Comparator

patients will receive usual care only

Intervention: Usual Care (Other)

Outcomes

Primary Outcomes

AIMS2 Quality of life

Time Frame: Baseline to 6 months after randomization

Change in health-related quality of life among participants, measured using validated patient-reported questionnaires (AIMS2) to assess physical, emotional, and social domains. The focus is on improvement in self-reported well-being and daily functioning.

Secondary Outcomes

  • DAS-28(Baseline to 6 months after randomization)
  • ASES(Baseline to 6 months after randomization)
  • MARS(Baseline to 6 months after randomization)
  • BDI(Baseline to 6 months after randomization)

Investigators

Sponsor
Hassan II University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Abdelaaziz Bounabe

Dr BOUNABE ABDELAAZI

Hassan II University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerAdvanced Lung CancerSmall Cell Lung Cancer Extensive StageStage IV Gastric CancerStage IV Hepatocellular CancerUnresectable Stage III Non-Small Cell Lung CancerStage IV Basal Cell CarcinomaStage IV Esophageal CancerStage IV Cutaneous Squamous Cell CarcinomaStage IV Renal Cell CarcinomaStage IV Head and Neck Squamous Cell CarcinomaStage IV Cervical CancerStage IV Endometrial CancerStage IV MesotheliomaImmune Checkpoint InhibitorsStage IV Non-Small Cell Lung CancerStage IV Merkel Cell CarcinomaStage IV Colorectal CancerImmunotherapyStage IV MelanomaUnresectable Non-Small Cell Lung CarcinomaStage IV Breast CancerStage IV Bladder Cancer
NCT04670445Massachusetts General Hospital199
Completed
Not Applicable
Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology PatientsMalignant Neoplasm
NCT02081794Case Comprehensive Cancer Center91
Unknown
Not Applicable
Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection FractionPatient Acceptance of Health CareHeart Failure
NCT06273085Medstar Health Baltimore500
Completed
Phase 4
Patient-Physician Partnership to Improve High Blood Pressure AdherenceCardiovascular DiseasesHypertension
NCT00123045National Heart, Lung, and Blood Institute (NHLBI)279
Completed
Not Applicable
Evaluation of an Education Program to Increase Knowledge and Participation in Clinical Trials Among Racial/Ethnic and Rural PopulationsMalignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
NCT06112002Ohio State University Comprehensive Cancer Center78